Results 161 to 170 of about 98,529 (269)

POLYCYSTIC OVARY SYNDROME: ORIGINS AND IMPLICATIONS: Genetics of polycystic ovary syndrome (PCOS). [PDF]

Reproduction
Louwers YV, Visser JA, Dunaif A, Laven JSE.   +3 more
europepmc   +1 more source

Ultrasonography in General Practice: Insights From an Implementation Study in a Low‐Income Neighborhood of Amsterdam

Sonography, Volume 13, Issue 1, March 2026.
ABSTRACT Background Ultrasonography is increasingly being used in primary care settings, facilitated by technological advancements, reduced device‐related costs, and improved access to training and support. It holds particular promise for underserved communities, where barriers such as co‐pays or long waiting lists can limit access to diagnostic ...
Ralf E. Harskamp, Britt Soddemann genaamd Keute, Constantijn Pleiter, Jelle C. L. Himmelreich   +3 more
wiley   +1 more source

New Challenges and Perspectives in Polycystic Ovary Syndrome. [PDF]

J Clin Med
Parker J, Hitch V.
europepmc   +1 more source

Polycystic Ovary Syndrome Revisited: Novel Insights and Updates. [PDF]

Int J Med Sci
Zhao W, Zhou J, Song Y, He M, Zhu X, Yu B, Gao W.   +6 more
europepmc   +1 more source

Semaglutide and tirzepatide effects on cardiovascular outcomes in people with overweight or obesity in the real world (STEER)

Diabetes, Obesity and Metabolism, Volume 28, Issue 3, Page 2403-2415, March 2026.
Abstract Aims To assess the real‐world effectiveness of semaglutide versus tirzepatide in reducing major adverse cardiovascular events (MACE) among patients with overweight/obesity and established atherosclerotic cardiovascular disease (ASCVD) without diabetes in an insured US population.
Lauren Wilson, Zhenxiang Zhao, Victoria Divino, Matthew Bassan, Bríain Ó. Hartaigh, Signe Stensen, Kerem Ozer   +6 more
wiley   +1 more source

Activation and DNA methylation of PANoptosis in polycystic ovary syndrome. [PDF]

PLoS One
Han Y, Han Y, Feng Y, Shan Y, Liu C, Wang K, Li X, Zhang S, Zhu X.   +8 more
europepmc   +1 more source

Personalized Models of Biological Barriers and Their Diseases: Recent Progress with Organs‐On‐Chips

Advanced Biology, Volume 10, Issue 2, February 2026.
Buck and Bugter et al. explore the architectural diversity and physiological functions of human barrier systems and reveal how organ‐on‐chip platforms, particularly those integrating patient‐derived cells, are advancing barrier disease modeling. They highlight how emerging biological and technological advances can be used to bridge the gap between ...
Franziska Buck, Jeroen Bugter, Gizem Yorukoglu, Mina Kazemzadeh Dastjerd, Thomas E. Winkler   +4 more
wiley   +1 more source

Cardiovascular Dysfunction in Polycystic Ovary Syndrome: Mitochondrial and Inflammatory Mechanisms. [PDF]

Biomed Res Int
Badejogbin OC, Agunloye MO, Chijioke-Agu OE, Olubiyi MV, Olugbuyiro SO, Soetan OA, Bamgbose OA, Olaleye TO.   +7 more
europepmc   +1 more source

Dynamic Memory‐Augmented Whale Optimization Algorithm (DMA‐WOA) as Feature Descriptor for Polycystic Ovary Syndrome Detection

Applied AI Letters, Volume 7, Issue 1, February 2026.
Proposed approach for this study. ABSTRACT This study introduces a dynamically memory‐adjusted whale optimization algorithm (DMA‐WOA) for feature selection in polycystic ovary syndrome (PCOS) diagnosis. To overcome the standard WOA's limitations in balancing exploration and exploitation, DMA‐WOA incorporated adaptive memory control to improve ...
Daniel Kwame Amissah, Leonard Mensah Boante, Solomon Mensah, Ebenezer Owusu, Justice Kwame Appati   +4 more
wiley   +1 more source

Glycolysis in polycystic ovary syndrome: pathogenesis and treatment. [PDF]

J Ovarian Res
Xing L, Shi M, Wang Z, Gao H, Li D, Guo R, Zhou X, Chen Y, Xu J, Liang Z, Li T, Zhang K, Shi H, Wang J, Wang R, Zhao R.   +15 more
europepmc   +1 more source